Evaluation of Chinese-Herbal-Medicine-Induced Herb-Drug Interactions: Focusing on Organic Anion Transporter 1

被引:7
|
作者
Lin, Chang-Ching [1 ]
Fan, Hsien-Yuan [1 ]
Kuo, Chien-Wen [2 ]
Pao, Li-Heng [1 ,3 ]
机构
[1] Natl Def Med Ctr, Sch Pharm, Taipei 114, Taiwan
[2] Cheng Hsin Gen Hosp, Div Pharm, Taipei 112, Taiwan
[3] TransWorld Univ, Dept Biotechnol, Yunlin 640, Taiwan
关键词
RENAL EPITHELIAL-CELLS; P-AMINOHIPPURATE PAH; LIQUID-CHROMATOGRAPHY; EXPRESSION CLONING; RAT; INULIN; FAMILY; ADEFOVIR; URINE; ACID;
D O I
10.1155/2012/967182
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
The consumption of Chinese herbal medicines (CHMs) is increasing exponentially. Many patients utilize CHMs concomitantly with prescription drugs in great frequency. Herb-drug interaction has hence become an important focus of study. Transporter-mediated herb-drug interactions have the potential to seriously influence drug efficacy and toxicity. Since organic anion transporter 1 (OAT1) is crucial in renal active secretion and drug-drug interactions, the possibility of modulation of OAT1-mediated drug transport should be seriously concerned. Sixty-three clinically used CHMs were evaluated in the study. An hOAT1-overexpressing cell line was used for the in vitro CHMs screening, and the effective candidates were administered to Wistar rats to access renal hemodynamics. The regulation of OAT1 mRNA expression was also examined for further evidence of CHMs affecting OAT1-mediated transport. Among all the 63 CHMs, formulae Gui Zhi Fu Ling Wan (GZ) and Chia Wei Hsiao Yao San (CW) exhibited significant inhibitions on hOAT1-mediated [H-3]-PAH uptake in vitro and PAH clearance and net secretion in vivo. Moreover, GZ showed concentration-dependent manners both in vitro and in vivo, and the decrease of rOAT1 mRNA expression indicated that GZ not only inhibited function of OAT1 but also suppressed expression of OAT1.
引用
收藏
页数:12
相关论文
共 43 条
  • [31] Prediction of the Renal Organic Anion Transporter 1 (OAT1)- Mediated Drug Interactions for LY404039, the Active Metabolite of Pomaglumetad Methionil
    Pak, Y. Anne
    Posada, Maria M. M.
    Bacon, James
    Long, Amanda
    Annes, William
    Witcher, Jennifer
    Mitchell, Malcolm
    Tirona, Rommel G. G.
    Hall, Stephen D. D.
    Hillgren, Kathleen M. M.
    PHARMACEUTICAL RESEARCH, 2023, 40 (11) : 2499 - 2511
  • [32] Prediction of the Renal Organic Anion Transporter 1 (OAT1)- Mediated Drug Interactions for LY404039, the Active Metabolite of Pomaglumetad Methionil
    Y. Anne Pak
    Maria M. Posada
    James Bacon
    Amanda Long
    William Annes
    Jennifer Witcher
    Malcolm Mitchell
    Rommel G. Tirona
    Stephen D. Hall
    Kathleen M. Hillgren
    Pharmaceutical Research, 2023, 40 : 2499 - 2511
  • [33] Acamprosate Is a Substrate of the Human Organic Anion Transporter (OAT) 1 without OAT3 Inhibitory Properties: Implications for Renal Acamprosate Secretion and Drug-Drug Interactions
    Antonescu, Irina E.
    Karlgren, Maria
    Pedersen, Maria L.
    Simoff, Ivailo
    Bergstrom, Christel A. S.
    Neuhoff, Sibylle
    Artursson, Per
    Steffansen, Bente
    Nielsen, Carsten Uhd
    PHARMACEUTICS, 2020, 12 (04)
  • [34] 6β-Hydroxycortisol Is an Endogenous Probe for Evaluation of Drug-Drug Interactions Involving a Multispecific Renal Organic Anion Transporter, OAT3/SLC22A8, in Healthy Subjects
    Imamura, Yuichiro
    Tsuruya, Yuri
    Damme, Katja
    Heer, Dominik
    Kumagai, Yuji
    Maeda, Kazuya
    Murayama, Nobuyuki
    Okudaira, Noriko
    Kurihara, Atsushi
    Izumi, Takashi
    Sugiyama, Yuichi
    Kusuhara, Hiroyuki
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (04) : 685 - 694
  • [35] Investigation of Fluorescent Substrates and Substrate-Dependent Interactions of a Drug Transporter Organic Anion Transporting Polypeptide 2B1 (OATP2B1)
    Tatsuya Kawasaki
    Yuichi Shiozaki
    Naoki Nomura
    Kumi Kawai
    Yuichi Uwai
    Tomohiro Nabekura
    Pharmaceutical Research, 2020, 37
  • [36] Investigation of Fluorescent Substrates and Substrate-Dependent Interactions of a Drug Transporter Organic Anion Transporting Polypeptide 2B1 (OATP2B1)
    Kawasaki, Tatsuya
    Shiozaki, Yuichi
    Nomura, Naoki
    Kawai, Kumi
    Uwai, Yuichi
    Nabekura, Tomohiro
    PHARMACEUTICAL RESEARCH, 2020, 37 (06)
  • [37] Herb-Drug Interactions: In Vivo and In Vitro Effect of Shenmai Injection, a Herbal Preparation, on the Metabolic Activities of Hepatic Cytochrome P450 3A1/2, 2C6, 1A2, and 2E1 in Rats
    Xia, Chun-hua
    Sun, Jian-guo
    Wang, Guang-ji
    Shang, Li-li
    Zhang, Xiao-xuan
    Zhang, Rong
    Peng, Ying
    Wang, Xiao-jin
    Hao, Hai-ping
    Xie, Lin
    Roberts, Michael S.
    PLANTA MEDICA, 2010, 76 (03) : 245 - 250
  • [38] Pharmacokinetics of gallic acid and protocatechuic acid in humans after dosing with Relinqing (RLQ) and the potential for RLQ-perpetrated drug-drug interactions on organic anion transporter (OAT) 1/3
    Li, Ziqiang
    Du, Xi
    Li, Yanfen
    Wang, Ruihua
    Liu, Changxiao
    Cao, Yanguang
    Wu, Weidang
    Sun, Jinxia
    Wang, Baohe
    Huang, Yuhong
    PHARMACEUTICAL BIOLOGY, 2021, 59 (01) : 757 - 768
  • [39] Utilizing single- and double-transfected cell models expressing human organic anion transporter 1 and human cytochrome P450 1A2 to investigate the interactions with ingredients of herbal medicines
    Qin, Zhiyuan
    Zhao, Lei
    Hu, Haihong
    Jiang, Huidi
    Yu, Lushan
    Zeng, Su
    XENOBIOTICA, 2017, 47 (07) : 576 - 583
  • [40] Quantitative Prediction of Transporter- and Enzyme-Mediated Clinical Drug-Drug Interactions of Organic Anion-Transporting Polypeptide 1B1 Substrates Using a Mechanistic Net-Effect Model
    Varma, Manthena V.
    Bi, Yi-an
    Kimoto, Emi
    Lin, Jian
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 351 (01): : 214 - 223